On July 18, 2018, PPMD and Capricor hosted a webinar to discuss the HOPE-2 trial. Capricor provided a brief background of CAP-1002 and its clinical development to date that has led to this exciting trial. The webinar also reviewed the trial design, eligibility criteria, and assessments that participants will need to complete if they participate in the trial, as well as the travel policy for participants who need to travel to a trial site.
by: Parent Project Muscular Dystrophy
